These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prevention of heart disease in the young coronary candidate. Kannel WB Prim Care; 1977 Jun; 4(2):229-43. PubMed ID: 586715 [TBL] [Abstract][Full Text] [Related]
23. Precursors and prevention of coronary artery disease. An overview. Barrow MV; Ramsey HW Mod Treat; 1972 May; 9(2):357-73. PubMed ID: 4563491 [No Abstract] [Full Text] [Related]
24. Risk factors for atherosclerosis. McGill HC Adv Exp Med Biol; 1978; 104():273-80. PubMed ID: 717136 [No Abstract] [Full Text] [Related]
25. [Particularities of hypertension in diabetic patient]. Valensi P Rev Prat; 2004 Mar; 54(6):633-6. PubMed ID: 15222614 [TBL] [Abstract][Full Text] [Related]
26. [Recommendations for practicing physicians with regard to the secondary prevention of ischemic heart disease]. Kardiologiia; 1986 Oct; 26(10):109-15. PubMed ID: 3795692 [No Abstract] [Full Text] [Related]
27. [Prophylactic and therapeutic perspectives in arteriosclerosis]. Masini V; Concina B Policlinico Prat; 1967 Jul; 74(27):901-24. PubMed ID: 4885120 [No Abstract] [Full Text] [Related]
28. Prevention of cardiovascular events in diabetes. Sigal R; Malcolm J; Arnaout A Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029 [No Abstract] [Full Text] [Related]
30. [Incidence and correction of nutrition-dependent cardiovascular risk factors in the aged population (3-year study)]. Lacatîş D; Ababei B; Blîndu G; Fiterman L; Lacatîş M; Creţeanu G Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(6):519-28. PubMed ID: 24248 [No Abstract] [Full Text] [Related]
31. Prevention of coronary heart-disease. A counterblast to present inactivity. Turner R; Ball K Lancet; 1973 Nov; 2(7838):1137-40. PubMed ID: 4128025 [No Abstract] [Full Text] [Related]
32. Prevention of cardiovascular disease among the elderly. Karvonen MJ Bull World Health Organ; 1988; 66(1):7-14. PubMed ID: 3260144 [TBL] [Abstract][Full Text] [Related]
33. Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease. Ragucci E; Zonszein J; Frishman WH Heart Dis; 2003; 5(1):18-33. PubMed ID: 12549986 [TBL] [Abstract][Full Text] [Related]
34. [Diabetes and hypertension. Results from the ADVANCE study]. Mehlsen J Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082 [No Abstract] [Full Text] [Related]
35. Role of oral anti-diabetic agents in modifying cardiovascular risk factors. Shin JJ; Rothman J; Farag A; McFarlane SI; Sowers JR Minerva Med; 2003 Dec; 94(6):401-8. PubMed ID: 14976468 [TBL] [Abstract][Full Text] [Related]
36. [Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES]. Agence Nationale d'Accréditation et d'Evaluation en Santé J Mal Vasc; 2000 Dec; 25(5):366-376. PubMed ID: 11148400 [No Abstract] [Full Text] [Related]
37. Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. Rolka DB; Fagot-Campagna A; Narayan KM Diabetes Care; 2001 Feb; 24(2):197-201. PubMed ID: 11213865 [TBL] [Abstract][Full Text] [Related]
38. Introduction to the 5th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy). Raz I; Cefalu WT; Ilkova H; Del Prato S Diabetes Care; 2016 Aug; 39 Suppl 2(Suppl 2):S113-4. PubMed ID: 27440822 [No Abstract] [Full Text] [Related]
39. Diet-related risk factors for human atherosclerosis: hyperlipidemia, hypertension, hyperglycemia--current status. Stamler J Adv Exp Med Biol; 1975; 60():125-58. PubMed ID: 1096560 [No Abstract] [Full Text] [Related]